GCAN — Greater Cannabis Share Price
- $0.59m
- $0.90m
- 11
- 26
- 29
- 11
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 0.01 | 0.05 | 0.01 | n/a | n/a | n/a | n/a | -100% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
The Greater Cannabis Company, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of cannabinoid therapeutics. The Company conducts medical research, and is pursuing clinical trials, to develop cannabis-based treatments for various medical conditions and their symptoms with an initial focus on neuropsychiatric disorders. The Company conducts clinical studies on and commercialize the cannabinoid-based therapeutic and concentrate on cannabis related investment and development opportunities through direct equity investments, joint ventures, licensing agreements or acquisitions. Its delivery technologies use a bio-adhesive, adjustable dose, and fully dissolvable, non-irritant patch, which provides needle free, intra-oral systemic drug delivery.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- January 13th, 2017
- Public Since
- July 9th, 2018
- No. of Shareholders
- 337
- No. of Employees
- 1
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 732,638,436
![Blurred out image of a map](https://www.stockopedia.com/assets/conversion/images/maps_placeholder.jpg)
- Address
- 15 Walker Ave Ste 101, BALTIMORE, 21208-4023
- Web
- https://gcanrx.com/
- Phone
- +1 4437384051
- Auditors
- OLAYINKA OYEBOLA & CO
Upcoming Events for GCAN
Similar to GCAN
1606
Pink Sheets on Nasdaq
Ablaze Technologies
Pink Sheets on Nasdaq
Accelerated Technologies Holding
Pink Sheets on Nasdaq
Acorn Energy
Pink Sheets on Nasdaq
Advanced Voice Recognition Systems
Pink Sheets on Nasdaq
FAQ
As of Today at 20:58 UTC, shares in Greater Cannabis are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Greater Cannabis last closed at $0.00 and the price had moved by +20% over the past 365 days. In terms of relative price strength the Greater Cannabis share price has outperformed the S&P500 Index by +0.71% over the past year.
There is no consensus recommendation for this security.
Greater Cannabis does not currently pay a dividend.
Greater Cannabis does not currently pay a dividend.
Greater Cannabis does not currently pay a dividend.
To buy shares in Greater Cannabis you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Greater Cannabis had a market capitalisation of $0.55m.
Here are the trading details for Greater Cannabis:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: GCAN
Based on an overall assessment of its quality, value and momentum Greater Cannabis is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Greater Cannabis. Over the past six months, its share price has underperformed the S&P500 Index by -20.1%.
As of the last closing price of $0.00, shares in Greater Cannabis were trading +0.66% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Greater Cannabis PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Greater Cannabis' management team is headed by:
- Aitan Zacharin - PRE